160 related articles for article (PubMed ID: 21163069)
1. [Microvascular density and VEGF expression in hepatocellular carcinoma after arterial chemoembolization].
Bao Y; Feng WM; Fei MY
Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):770-1. PubMed ID: 21163069
[No Abstract] [Full Text] [Related]
2. Endostatin inhibits angiogenesis in hepatocellular carcinoma after transarterial chemoembolization.
Bao Y; Feng WM; Tang CW; Zheng YY; Gong HB; Hou EG
Hepatogastroenterology; 2012; 59(117):1566-8. PubMed ID: 22456329
[TBL] [Abstract][Full Text] [Related]
3. Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion.
Jin YJ; Lee JW; Lee OH; Chung HJ; Kim YS; Lee JI; Cho SG; Jeon YS; Lee KY; Ahn SI; Shin WY
J Gastroenterol Hepatol; 2014 May; 29(5):1056-64. PubMed ID: 24372785
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of endostar combined with transcatheter arterial chemoembolization and analysis of vascular endothelial factor and C-reactive protein levels in patients with advanced hepatocellular carcinoma under contrast enhanced ultrasound.
Wang Y; Xuan Z; Zheng X; Han R; Zhou L; Liu H; Liu Y
J BUON; 2019; 24(6):2394-2401. PubMed ID: 31983111
[TBL] [Abstract][Full Text] [Related]
5. Effect of preoperative transcatheter arterial chemoembolization on angiogenesis of hepatocellular carcinoma cells.
Xiao EH; Guo D; Bian DJ
World J Gastroenterol; 2009 Sep; 15(36):4582-6. PubMed ID: 19777619
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of vascular endothelial growth factor in hepatocellular carcinoma after transcatheter arterial chemoembolization.
Wang B; Xu H; Gao ZQ; Ning HF; Sun YQ; Cao GW
Acta Radiol; 2008 Jun; 49(5):523-9. PubMed ID: 18568538
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of endostar combined with transcatheter arterial chemoembolization and analysis of vascular endothelial factor and C-reactive protein levels in patients with advanced hepatocellular carcinoma under contrast enhanced ultrasound.
Wang Y; Xuan Z; Zheng X; Han R; Zhou L; Liu H; Liu Y
J BUON; 2020; 25(1):407-414. PubMed ID: 32277662
[TBL] [Abstract][Full Text] [Related]
8. Study on the changes in microvessel density in hepatocellular carcinoma following transcatheter arterial chemoembolization.
Yi J; Liao X; Yang Z; Li X
J Tongji Med Univ; 2001; 21(4):321-2, 331. PubMed ID: 12539559
[TBL] [Abstract][Full Text] [Related]
9. Targeting vessels to treat hepatocellular carcinoma.
Romanque P; Piguet AC; Dufour JF
Clin Sci (Lond); 2008 Apr; 114(7):467-77. PubMed ID: 18302534
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
[TBL] [Abstract][Full Text] [Related]
11. [Vascular endothelial growth factor and the effects of endostatin on the inhibition of tumor angiogenesis in treating hepatocarcinomas].
Deng JY; He S
Zhonghua Gan Zang Bing Za Zhi; 2005 Apr; 13(4):313-4. PubMed ID: 15850529
[No Abstract] [Full Text] [Related]
12. Hypoxia and tumor angiogenesis in the era of hepatocellular carcinoma transarterial loco-regional treatments.
Petrillo M; Patella F; Pesapane F; Suter MB; Ierardi AM; Angileri SA; Floridi C; de Filippo M; Carrafiello G
Future Oncol; 2018 Dec; 14(28):2957-2967. PubMed ID: 29712486
[TBL] [Abstract][Full Text] [Related]
13. Transportal Chemoembolization as Salvage Hepatocellular Carcinoma Therapy to Maintain Liver Transplant Candidacy.
Tasse JC; Sailer A; Jakate S; Arslan B
J Vasc Interv Radiol; 2019 Oct; 30(10):1651-1654.e1. PubMed ID: 31171398
[No Abstract] [Full Text] [Related]
14. Tumoral and angiogenesis factors in hepatocellular carcinoma after locoregional therapy.
Farris AB; Dursun N; Dhanasekaran R; Coban I; McIntosh EB; Adsay NV; Kim HS
Pathol Res Pract; 2012 Jan; 208(1):15-21. PubMed ID: 22088254
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma.
Wu XZ; Xie GR; Chen D
J Gastroenterol Hepatol; 2007 Aug; 22(8):1178-82. PubMed ID: 17559361
[TBL] [Abstract][Full Text] [Related]
16. [Transcatheter arterial chemoembolization for hepatocellular carcinoma:current topics].
Takaki H; Sato Y; Yamakado K
Nihon Shokakibyo Gakkai Zasshi; 2017; 114(9):1602-1610. PubMed ID: 28883289
[No Abstract] [Full Text] [Related]
17. Hepatocellular carcinoma vascularization: from the most common to the lesser known arteries.
Cazejust J; Bessoud B; Colignon N; Garcia-Alba C; Planché O; Menu Y
Diagn Interv Imaging; 2014 Jan; 95(1):27-36. PubMed ID: 23978434
[TBL] [Abstract][Full Text] [Related]
18. [9. Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma].
Araki T
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2016; 72(10):1039-1048. PubMed ID: 27760904
[No Abstract] [Full Text] [Related]
19. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver.
El-Assal ON; Yamanoi A; Soda Y; Yamaguchi M; Igarashi M; Yamamoto A; Nabika T; Nagasue N
Hepatology; 1998 Jun; 27(6):1554-62. PubMed ID: 9620326
[TBL] [Abstract][Full Text] [Related]
20. Transcatheter arterial chemoembolization of hepatocellular carcinoma.
Chung JW
Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1236-41. PubMed ID: 9730381
[No Abstract] [Full Text] [Related]
[Next] [New Search]
